Canada
· Delayed Price · Currency is CAD ASTI Statistics
Total Valuation
Aquarius Surgical Technologies has a market cap or net worth of CAD 413,988. The enterprise value is 4.49 million.
| Market Cap | 413,988 |
| Enterprise Value | 4.49M |
Important Dates
The next estimated earnings date is Tuesday, November 26, 2024.
| Earnings Date | Nov 26, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Aquarius Surgical Technologies has 27.60 million shares outstanding. The number of shares has increased by 6.85% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 27.60M |
| Shares Change (YoY) | +6.85% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 3.76% |
| Owned by Institutions (%) | n/a |
| Float | 13.41M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.34 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.66 |
| EV / Sales | 25.35 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.09
| Current Ratio | 0.09 |
| Quick Ratio | 0.07 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.75 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -54.83% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.30 |
| Inventory Turnover | 2.71 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +200.00% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +200.00% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 44.92 |
| Average Volume (20 Days) | 24,504 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Aquarius Surgical Technologies had revenue of CAD 177,004 and -793,268 in losses. Loss per share was -0.03.
| Revenue | 177,004 |
| Gross Profit | 115,078 |
| Operating Income | -524,856 |
| Pretax Income | -786,205 |
| Net Income | -793,268 |
| EBITDA | -520,508 |
| EBIT | -524,856 |
| Loss Per Share | -0.03 |
Balance Sheet
The company has 110,743 in cash and 4.18 million in debt, giving a net cash position of -4.07 million or -0.15 per share.
| Cash & Cash Equivalents | 110,743 |
| Total Debt | 4.18M |
| Net Cash | -4.07M |
| Net Cash Per Share | -0.15 |
| Equity (Book Value) | -4.83M |
| Book Value Per Share | -0.17 |
| Working Capital | -1.78M |
Cash Flow
| Operating Cash Flow | -262,516 |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 65.01% |
| Operating Margin | -296.52% |
| Pretax Margin | -444.17% |
| Profit Margin | n/a |
| EBITDA Margin | -294.07% |
| EBIT Margin | -296.52% |
| FCF Margin | n/a |
Dividends & Yields
Aquarius Surgical Technologies does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.85% |
| Shareholder Yield | -6.85% |
| Earnings Yield | -191.61% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Aquarius Surgical Technologies has an Altman Z-Score of -92.7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -92.7 |
| Piotroski F-Score | n/a |